Skip to main content

Table 4 Post TAVI pacemaker implantation analysis

From: Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves

Post TAVI PPM analysis (n = 15)

 

Indications

 

AVB type III

8 /15 (53.3%)

LBBB, HR < 40 bpm; symptoms

3/15 (20%)

Tachy-brady syndrome with rate < 40 bpm

1/15 (6.7%)

Slow Atrial fibrillation < 40 bpm; hypotension

1/15 (6.7%)

Slow Atrial fibrillation;

long pause > 5 s

1/15 (6.7%)

Junctional/ Atrial fibrillation, with HR < 40 bpm

1/15 (6.7%)

DDDR

5/15 (33.3%)

VVIR

10/15 (66.6%)

Timing for PPM post TAVI

 

Within 24 h

4/15 (26.7%)

D1-D3

6/16 (37.5%)

>D3 – D7

5/15 (33.3%)

More than 1 week

3/15 (20%)

VP & AP < 5% at 1 year of interrogation

6/15 (40%)

- AVB III as indication

3/6

- Tachy-brady

1/6

- Long pause

1/6

- Slow AF + LBBB + rate < 40

1 /6

Time for implant post TAVI for patients with VP/AP < 5% & ECG native > 60 bpm at Follow up

- Within 24 h

2/6

- D1 to D3

1/6

- D3 to D7

2/6

- More than 1 week

1/6